Baicalein Restores the Balance of Th17/Treg Cells via Aryl Hydrocarbon Receptor to Attenuate Colitis

As one of the ligands of aryl hydrocarbon receptor (AhR), baicalein, isolated from Scutellaria baicalensis Georgi, has been proved to exert potential therapeutic effects on ulcerative colitis (UC), but its therapeutic mechanism remains obscure. Authentically, ulcerative colitis can be alleviated by...

Full description

Saved in:
Bibliographic Details
Main Authors: Chang Liu, Yanyang Li, Yanping Chen, Shaowei Huang, Xiaojing Wang, Shuang Luo, Yulin Su, Lian Zhou, Xia Luo
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2020/5918587
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566355787776000
author Chang Liu
Yanyang Li
Yanping Chen
Shaowei Huang
Xiaojing Wang
Shuang Luo
Yulin Su
Lian Zhou
Xia Luo
author_facet Chang Liu
Yanyang Li
Yanping Chen
Shaowei Huang
Xiaojing Wang
Shuang Luo
Yulin Su
Lian Zhou
Xia Luo
author_sort Chang Liu
collection DOAJ
description As one of the ligands of aryl hydrocarbon receptor (AhR), baicalein, isolated from Scutellaria baicalensis Georgi, has been proved to exert potential therapeutic effects on ulcerative colitis (UC), but its therapeutic mechanism remains obscure. Authentically, ulcerative colitis can be alleviated by regulating the differentiation of naïve CD4+ T cells via AhR activation. So, our study planned to prove the hypothesis that baicalein protected mice against UC by regulating the balance of Th17/Treg cells via AhR activation. Immunofluorescence and western blot results showed that baicalein could promote AhR activation and induce it to transfer to the nucleus. We further determined the effect of baicalein on naïve CD4+ T cell differentiation in vitro by magnetic cell separation and drug intervention. The results showed that baicalein could promote Treg cell differentiation by activating AhR. In vivo study, UC mice were established by free drinking of dextran sulfate sodium (DSS) for 7 days and then were orally administrated by baicalein (10, 20, and 40 mg/kg), TCDD (AhR agonist), and CH223191 (antagonist). The results demonstrated that baicalein improved the symptoms of UC mice, regulated the balance of Th17/Treg cells, and restored the balance of proinflammatory cytokines such as IL-17, IL-6, and TNF-α; anti-inflammatory cytokines such as IL-10 and TGF-β; and epithelial protective cytokine IL-22 in UC mice, and these effects were related to AhR. Taken together, our research found that baicalein might be a potential drug for UC via regulating Treg cell differentiation and maintaining immune homeostasis and attempted to shed a light on the pivotal role of AhR in these effects.
format Article
id doaj-art-9f568cf1ecd44f728948144cb8e1055b
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-9f568cf1ecd44f728948144cb8e1055b2025-02-03T01:04:25ZengWileyMediators of Inflammation0962-93511466-18612020-01-01202010.1155/2020/59185875918587Baicalein Restores the Balance of Th17/Treg Cells via Aryl Hydrocarbon Receptor to Attenuate ColitisChang Liu0Yanyang Li1Yanping Chen2Shaowei Huang3Xiaojing Wang4Shuang Luo5Yulin Su6Lian Zhou7Xia Luo8School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, ChinaSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, ChinaSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, ChinaSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, ChinaSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, ChinaSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, ChinaSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, ChinaSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, ChinaSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, ChinaAs one of the ligands of aryl hydrocarbon receptor (AhR), baicalein, isolated from Scutellaria baicalensis Georgi, has been proved to exert potential therapeutic effects on ulcerative colitis (UC), but its therapeutic mechanism remains obscure. Authentically, ulcerative colitis can be alleviated by regulating the differentiation of naïve CD4+ T cells via AhR activation. So, our study planned to prove the hypothesis that baicalein protected mice against UC by regulating the balance of Th17/Treg cells via AhR activation. Immunofluorescence and western blot results showed that baicalein could promote AhR activation and induce it to transfer to the nucleus. We further determined the effect of baicalein on naïve CD4+ T cell differentiation in vitro by magnetic cell separation and drug intervention. The results showed that baicalein could promote Treg cell differentiation by activating AhR. In vivo study, UC mice were established by free drinking of dextran sulfate sodium (DSS) for 7 days and then were orally administrated by baicalein (10, 20, and 40 mg/kg), TCDD (AhR agonist), and CH223191 (antagonist). The results demonstrated that baicalein improved the symptoms of UC mice, regulated the balance of Th17/Treg cells, and restored the balance of proinflammatory cytokines such as IL-17, IL-6, and TNF-α; anti-inflammatory cytokines such as IL-10 and TGF-β; and epithelial protective cytokine IL-22 in UC mice, and these effects were related to AhR. Taken together, our research found that baicalein might be a potential drug for UC via regulating Treg cell differentiation and maintaining immune homeostasis and attempted to shed a light on the pivotal role of AhR in these effects.http://dx.doi.org/10.1155/2020/5918587
spellingShingle Chang Liu
Yanyang Li
Yanping Chen
Shaowei Huang
Xiaojing Wang
Shuang Luo
Yulin Su
Lian Zhou
Xia Luo
Baicalein Restores the Balance of Th17/Treg Cells via Aryl Hydrocarbon Receptor to Attenuate Colitis
Mediators of Inflammation
title Baicalein Restores the Balance of Th17/Treg Cells via Aryl Hydrocarbon Receptor to Attenuate Colitis
title_full Baicalein Restores the Balance of Th17/Treg Cells via Aryl Hydrocarbon Receptor to Attenuate Colitis
title_fullStr Baicalein Restores the Balance of Th17/Treg Cells via Aryl Hydrocarbon Receptor to Attenuate Colitis
title_full_unstemmed Baicalein Restores the Balance of Th17/Treg Cells via Aryl Hydrocarbon Receptor to Attenuate Colitis
title_short Baicalein Restores the Balance of Th17/Treg Cells via Aryl Hydrocarbon Receptor to Attenuate Colitis
title_sort baicalein restores the balance of th17 treg cells via aryl hydrocarbon receptor to attenuate colitis
url http://dx.doi.org/10.1155/2020/5918587
work_keys_str_mv AT changliu baicaleinrestoresthebalanceofth17tregcellsviaarylhydrocarbonreceptortoattenuatecolitis
AT yanyangli baicaleinrestoresthebalanceofth17tregcellsviaarylhydrocarbonreceptortoattenuatecolitis
AT yanpingchen baicaleinrestoresthebalanceofth17tregcellsviaarylhydrocarbonreceptortoattenuatecolitis
AT shaoweihuang baicaleinrestoresthebalanceofth17tregcellsviaarylhydrocarbonreceptortoattenuatecolitis
AT xiaojingwang baicaleinrestoresthebalanceofth17tregcellsviaarylhydrocarbonreceptortoattenuatecolitis
AT shuangluo baicaleinrestoresthebalanceofth17tregcellsviaarylhydrocarbonreceptortoattenuatecolitis
AT yulinsu baicaleinrestoresthebalanceofth17tregcellsviaarylhydrocarbonreceptortoattenuatecolitis
AT lianzhou baicaleinrestoresthebalanceofth17tregcellsviaarylhydrocarbonreceptortoattenuatecolitis
AT xialuo baicaleinrestoresthebalanceofth17tregcellsviaarylhydrocarbonreceptortoattenuatecolitis